EMN
50
-5
KR
52
2
NOC
54
4
ISRG
77
2
RCL
87
4
NDAQ
63
4
MA
67
3
WU
22
2
T
45
4
LRCX
52
2
VFC
62
-3
MCO
77
7
CAT
62
-4
M
36
-6
XRAY
29
3
MDLZ
36
4
MET
60
2
TJX
62
3
ES
31
3
GE
71
7
EMN
50
-5
KR
52
2
NOC
54
4
ISRG
77
2
RCL
87
4
NDAQ
63
4
MA
67
3
WU
22
2
T
45
4
LRCX
52
2
VFC
62
-3
MCO
77
7
CAT
62
-4
M
36
-6
XRAY
29
3
MDLZ
36
4
MET
60
2
TJX
62
3
ES
31
3
GE
71
7
Financhill
Back

Kinsale Capital Group Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
53

KNSL
Kinsale Capital Group

Last Price:
456.32
Seasonality Move:
6.48%
Buy
100

RYTM
Rhythm Pharmaceuticals

Last Price:
67.31
Seasonality Move:
9.98%
Buy
53
Kinsale Capital Group (KNSL) is a Buy

Is Kinsale Capital Group a Buy, Sell or Hold?

  • The current Kinsale Capital Group [KNSL] share price is $456.36. The Score for KNSL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KNSL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

KNSL Stock Price Chart

What is Kinsale Capital Group's stock price today?

  • The Kinsale Capital Group share price today is $456.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $67.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KNSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.48 Sell
Relative Strength Index (14 RSI): 53.78 Buy
Chaikin Money Flow: 107571 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (435.63 - 471.13) Buy
Bollinger Bands (100): (404.8 - 478.48) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 81.29 Buy
Chaikin Money Flow: 966983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.36 - 56.78) Buy
Bollinger Bands (100): (43.87 - 52.87) Buy

KNSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 436.64 Buy
20-day SMA: 449.81 Buy
50-day SMA: 458.55 Sell
200-day SMA: 440.61 Buy
8-day EMA: 443.47 Buy
20-day EMA: 447.3 Buy
50-day EMA: 451.71 Buy
200-day EMA: 431.12 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.18 Buy
20-day SMA: 52.43 Buy
50-day SMA: 50.91 Buy
200-day SMA: 45.07 Buy
8-day EMA: 58.59 Buy
20-day EMA: 54.14 Buy
50-day EMA: 51.2 Buy
200-day EMA: 44.61 Buy

Kinsale Capital Group Earnings Growth & KNSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.50 per share, and an increase next year of $2.44 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Kinsale Capital Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):